Medicare Enrolled
Dr. Ernesto Bustinza Linares, M.D.
Hematology · Deland, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bustinza Linares from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bustinza Linares?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bustinza Linares
Dr. Ernesto Bustinza Linares is a hematology specialist in Deland, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bustinza Linares performed 104,931 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bustinza Linares received a total of $18,795 from 85 pharmaceutical and/or device companies across 989 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bustinza Linares is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 43% volume in FL
$18,795 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗104,931
Medicare services
Top 43% in FL for hematology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
58,650 | $0 | $4 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
12,800 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 8,190 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,420 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,090 | $6 | $23 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,502 | $36 | $108 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,058 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,922 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,718 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,000 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
790 | $96 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
673 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 612 | $0 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $66 | $239 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
345 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
339 | $95 | $378 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
337 | $48 | $189 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
262 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
250 | $22 | $84 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
183 | $2 | $41 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
130 | $1 | $3 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
123 | $15 | $56 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
107 | $4 | $15 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
104 | $21 | $79 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
91 | $16 | $59 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
90 | $24 | $156 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
85 | $10 | $42 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
84 | $2 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
78 | $2 | $8 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
73 | $49 | $178 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
60 | $28 | $156 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
53 | $1 | $7 |
| New patient office visit, complex (60-74 min) | 49 | $169 | $585 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
46 | $3 | $11 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
44 | $137 | $556 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
43 | $42 | $170 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $140 | $474 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $121 | $453 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
27 | $73 | $277 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $94 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
59.6% high complexity
35.3% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,795
Total received (2018-2024)
Avg $2,685/year across 7 years
Top 26% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
989
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,879
2023
$3,778
2022
$2,697
2021
$2,589
2020
$1,857
2019
$2,482
2018
$2,512
Payments by company (2024)
Celgene Corporation
$395
Gilead Sciences, Inc.
$340
Novartis Pharmaceuticals Corporation
$276
PFIZER INC.
$215
Merck Sharp & Dohme LLC
$175
AstraZeneca Pharmaceuticals LP
$151
Daiichi Sankyo Inc.
$100
BeiGene USA, Inc.
$94
ABBVIE INC.
$92
Pharmacosmos Therapeutics Inc.
$82
GENZYME CORPORATION
$80
Lilly USA, LLC
$74
E.R. Squibb & Sons, L.L.C.
$69
Astellas Pharma US Inc
$62
TerSera Therapeutics LLC
$59
Kite Pharma, Inc.
$57
SOBI, INC
$56
ARRAY BIOPHARMA INC
$53
Janssen Biotech, Inc.
$46
JAZZ PHARMACEUTICALS INC.
$42
SERVIER PHARMACEUTICALS LLC
$40
ADC Therapeutics America, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$33
Genmab U.S., Inc.
$32
Acrotech Biopharma Inc.
$25
GlaxoSmithKline, LLC.
$23
Eisai Inc.
$23
Janssen Pharmaceuticals, Inc
$22
Blueprint Medicines Corporation
$21
Alexion Pharmaceuticals, Inc.
$20
SpringWorks Therapeutics, Inc.
$18
Exelixis Inc.
$18
Regeneron Healthcare Solutions, Inc.
$16
Incyte Corporation
$15
Genentech USA, Inc.
$15
Top 3 companies account for 35.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,455
Janssen Biotech, Inc.
$1,064
Celgene Corporation
$1,036
E.R. Squibb & Sons, L.L.C.
$964
Amgen Inc.
$902
PFIZER INC.
$768
GENZYME CORPORATION
$618
Genentech USA, Inc.
$548
AstraZeneca Pharmaceuticals LP
$529
Gilead Sciences, Inc.
$474
Seagen Inc.
$470
Merck Sharp & Dohme LLC
$432
Merck Sharp & Dohme Corporation
$428
Daiichi Sankyo Inc.
$427
Lilly USA, LLC
$421
Astellas Pharma US Inc
$396
Takeda Pharmaceuticals U.S.A., Inc.
$362
Pharmacyclics LLC, An AbbVie Company
$303
Bayer HealthCare Pharmaceuticals Inc.
$294
NOVARTIS PHARMACEUTICALS CORPORATION
$285
Kite Pharma, Inc.
$204
TerSera Therapeutics LLC
$199
Foundation Medicine, Inc.
$180
Ipsen Biopharmaceuticals, Inc
$165
Pharmacyclics LLC, an AbbVie Company
$155
ABBVIE INC.
$155
Incyte Corporation
$153
Regeneron Healthcare Solutions, Inc.
$150
EISAI INC.
$147
BeiGene USA, Inc.
$147
Alexion Pharmaceuticals, Inc.
$146
Seattle Genetics, Inc.
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$128
Puma Biotechnology, Inc.
$126
MACROGENICS, INC.
$125
Eisai Inc.
$121
JAZZ PHARMACEUTICALS INC.
$119
Pharmacosmos Therapeutics Inc.
$118
ARRAY BIOPHARMA INC
$115
Mirati Therapeutics, Inc.
$103
SOBI, INC
$99
GlaxoSmithKline, LLC.
$96
EMD Serono, Inc.
$83
Exelixis Inc.
$79
Clovis Oncology, Inc.
$62
Genmab U.S., Inc.
$61
MorphoSys, US Inc.
$59
AMAG Pharmaceuticals, Inc.
$57
SERVIER PHARMACEUTICALS LLC
$56
MEDIVATION FIELD SOLUTIONS LLC
$51
Stemline Therapeutics Inc.
$50
Agios Pharmaceuticals, Inc.
$49
Sun Pharmaceutical Industries Inc.
$47
Acrotech Biopharma Inc.
$46
G1 Therapeutics, Inc.
$46
EUSA Pharma (US) LLC
$45
Global Blood Therapeutics, Inc.
$44
CTI BioPharma Corp.
$41
Taiho Oncology, Inc.
$41
Sobi, Inc
$41
ADC Therapeutics America, Inc.
$39
Rigel Pharmaceuticals, Inc.
$39
TESARO, Inc.
$37
Janssen Pharmaceuticals, Inc
$36
West Therapeutics Development, LLC
$33
GT Medical Technologies, Inc
$31
Shire North American Group Inc
$28
Lexicon Pharmaceuticals, Inc.
$25
AbbVie Inc.
$23
AVEO Pharmaceuticals, Inc.
$21
Acrotech Biopharma LLC
$21
Blueprint Medicines Corporation
$21
Karyopharm Therapeutics Inc.
$21
CSL Behring
$20
SpringWorks Therapeutics, Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
Dova Pharmaceuticals
$17
Dendreon Pharmaceuticals LLC
$16
TAIHO ONCOLOGY, INC.
$16
Aurobindo Pharma USA, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$14
Sysmex Inostics Inc
$14
Verastem, Inc.
$14
MAYNE PHARMA INC.
$14
Adaptive Biotechnologies Corporation
$13
Top 3 companies account for 29.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Folotyn · GAMMATILE · GAZYVA · GILOTRIF · GIVLAARI · GammaTile · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO (sonidegib) capsules · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · Prolia · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · Subsys · Sylvant · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
8
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH DELAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bustinza Linares is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bustinza Linares experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bustinza Linares performed 58,650 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bustinza Linares receive payments from pharmaceutical companies?
Yes. Dr. Bustinza Linares received a total of $18,795 from 85 companies across 989 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bustinza Linares's costs compare to other hematologists in Deland?
Dr. Bustinza Linares's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bustinza Linares) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Deland
Browse hematologists in Deland ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology